Can You Take Mounjaro With Other Conditions and Medicines?

Mounjaro is a dual GIP and GLP-1 receptor agonist, and its effects on digestion, appetite, and metabolism mean that several existing conditions and medicines are worth discussing with your prescriber before or during treatment. The following covers the most commonly asked-about situations — always in general terms, since individual suitability is a clinical decision.

Gallstones and gallbladder conditions

GLP-1 receptor agonists, including tirzepatide, have been associated with gallbladder-related events in clinical studies, including gallstones (cholelithiasis) and gallbladder inflammation. If you have a history of gallstones or gallbladder disease, your prescriber needs to know before you start — and if you develop sudden, severe upper-abdominal pain while taking Mounjaro, contact a healthcare professional promptly. This is flagged as a special-care topic in the official product information.

Thyroid conditions — underactive thyroid and hypothyroidism

Many people with hypothyroidism or an underactive thyroid are prescribed Mounjaro, often alongside levothyroxine or thyroxine. Whether this combination is appropriate depends on how well the thyroid condition is controlled and your full clinical picture. For more detail on this specific combination, see our page on taking Mounjaro with an underactive thyroid and the dedicated page on Mounjaro and thyroxine.

Type 2 diabetes and metformin

Mounjaro is prescribed for both weight management and blood-sugar control. People with type 2 diabetes are frequently taking metformin alongside it. Your prescriber will monitor how the combination affects your blood glucose. If you also take insulin or other medicines that lower blood sugar, the risk of hypoglycaemia is worth discussing explicitly — dose adjustments to those medicines may be needed, and that decision rests entirely with your prescriber.

Mental health medicines — antidepressants and others

Sertraline, citalopram, fluoxetine, and amitriptyline are among the antidepressants that people commonly ask about. There is no blanket contraindication, but slower gastric emptying caused by tirzepatide can theoretically affect the absorption timing of oral medicines. Your prescriber and pharmacist are the right people to assess this for your specific combination. Mood changes are also listed among side effects to monitor — if you notice low mood or unusual mood shifts, report them to your healthcare professional.

Other conditions and medicines frequently asked about

People ask about a wide range of situations alongside Mounjaro, including:

• PCOS — Mounjaro is sometimes prescribed for people with polycystic ovary syndrome; suitability is assessed by the prescriber.
• High cholesterol and statins — see our page on Mounjaro and statins for general information on this common combination.
• Fatty liver disease — our page on Mounjaro and fatty liver covers what is generally understood.
• HRT, propranolol, and blood thinners — these interactions require individual clinical review; raise each one specifically with your prescriber or pharmacist.
• IBS, Crohn's disease, ulcerative colitis, and diverticulitis — GLP-1 medicines affect gut motility, so existing gastrointestinal conditions are particularly relevant to discuss before starting.
• History of pancreatitis — this is a special-care topic. Tirzepatide has been associated with pancreatitis in post-marketing reports. A history of pancreatitis is a factor your prescriber must weigh carefully.
• Heart failure, heart problems, and kidney disease — suitability depends on severity and stability; your prescriber will assess based on your clinical history.
• Asthma, antibiotics, methotrexate, and flu — general interactions and short-term illness questions are best directed to your prescriber or pharmacist, who can review your full medicine list.

For a broader overview of how tirzepatide works in the body, the how Mounjaro works guide provides useful background.

When you are managing Mounjaro alongside other conditions or medicines, having a clear, organised record of what you experience day-to-day becomes genuinely valuable — especially when it comes to prescriber appointments.

GLP Trackr's side-effect and symptom tracker lets you log how you feel after each dose — nausea, abdominal discomfort, fatigue, mood shifts, or anything else you notice — and see patterns over time. Rather than trying to recall 'how bad was the nausea three weeks ago?', you have a dated log you can share directly with your prescriber. The app's doctor report feature turns that data into a clear summary, so your appointments become more informed and more efficient.

If you are monitoring other health markers alongside your Mounjaro journey — weight, energy, sleep, or how your appetite is changing — the daily check-in captures all of this in under a minute each morning, building a picture that is far more useful than memory alone.

Important: GLP Trackr is a tracking and journalling app — it is not a medical service and cannot tell you whether any specific combination of medicines or conditions is safe for you. Any concern about your health, a symptom that is severe or persistent, or a question about whether it is safe to continue Mounjaro alongside another condition or medicine should be directed to your prescriber or doctor promptly. If you have a history of pancreatitis or gallbladder disease and experience sudden abdominal pain, seek medical attention without delay. Side effects can be reported to your national pharmacovigilance scheme (such as the UK's Yellow Card scheme) and to your healthcare professional.

Ready to keep a clearer record of your journey? Download GLP Trackr on the App Store or Google Play and try it free for 7 days — your prescriber will thank you for the detail.